Shakuyaku-kanzo-to, a traditional Chinese medicine (Kampo medicine), has been used for its antispasmodic and muscle relaxation effects in treatment of colic, lumbago, ischialgia, cramps, tension of cervical muscles and distortion. 1) This prescription consists of licorice root (Glycyrrhizae radix) and peony root (Paeoniae radix). The combined effects of glycyrrhizin (GL) in licorice root and paeoniflorin in peony root act synergistically to block neuromuscular junctions in skeletal muscle.
This prescription consists of licorice root (Glycyrrhizae radix) and peony root (Paeoniae radix). The combined effects of glycyrrhizin (GL) in licorice root and paeoniflorin in peony root act synergistically to block neuromuscular junctions in skeletal muscle.
2) Licorice root is one of the most frequently used crude drugs in Kampo medicine.
3) Its active ingredient is GL, which has been reported to show various pharmacological effects such as steroid-like, 4) anti-inflammatory, 5) and anti-viral 6) actions. On the other hand, GL is known to be hydrolyzed to glycyrrhetic acid (GA), the aglycone of GL, by human intestinal bacteria prior to absorption, 7) although GL is not hydrolyzed to GA, but to glycyrrhetic acid mono-glucuronide (GAMG), by human liver b-D-glucuronidase. 8) GAMG is an intermediate in the hydrolysis of GL to GA. Moreover, when GL is orally administered to rats, it is detected in the plasma, but its bioavailability is lower than that of GA. 9) These results suggest that GL is hydrolyzed by intestinal bacteria and that most of the GA formed is absorbed from the gastrointestinal tract. Therefore, a method for determination of GL and its metabolites is necessary to investigate the metabolism of GL in Kampo medicine. However, there have been no reports regarding simultaneous analysis of GL, GA and GAMG. Furthermore, the limit of detection is important to determine the metabolites present at low levels.
The study presented here describes a simple, sensitive and reproducible semi-micro HPLC method for simultaneous determination of these compounds in rat fecal suspension with Shakuyaku-kanzo-to after anaerobic incubation in vitro.
MATERIALS AND METHODS

Materials
The crude drugs were purchased from Tochimototenkaido (Osaka, Japan). GL and GAMG and GA were purchased from Wako Pure Chemical Industries (Wako: Osaka, Japan) and Nacalai Tesque (Kyoto, Japan), respectively. HPLC grade acetonitrile and analytical reagent grade phosphoric acid (85%) were purchased from Wako. Ultrapure distilled water with a resistivity greater than 18 MW was prepared with deionized-distilled water. The organic solvents and other chemical reagents were of analytical reagent grade, and were supplied by Wako.
Preparation of Decoction Daily dosages of Shakuyakukanzo-to (licorice root 6 g, peony root 6 g) 3) were prepared as follows: the daily dosage of crude drugs was boiled with 500 ml of water on an electric heater for more than 40 min, halving the original volume. The decoction was filtered through a colander while hot, and after cooling the volume was adjusted to 1000 ml with water. An aliquot of the adjusted decoction was diluted to 10-fold dilution with water, and the diluted decoction was filtered through a Sartorius membrane (Minisart RC 15, pore size: 0.45 mm, Japan Sartorius, Tokyo, Japan) and analyzed as the decoction.
Instrumentation and HPLC Analysis The HPLC apparatus was an Agilent (Waldbronn, Germany) system composed of an HP1100 Series Binary Pump and an HP1100 Series Autosampler (set at 5-ml). The detection wavelength was set at 254 nm for determination and in the range of 200 to 500 nm for validation of peak purity. An HP1100 Series 3D ChemStation (Agilent) was used for data acquisition and integration. Separations were carried out with a TSKgel ODS80TsQA reversed-phase column (particle size of the packing 5 mm, 150ϫ2.0 mm i.d.). The mobile phase was a gradient system with 200 ml · l Ϫ1 (ca. 0.017%) phosphoric acid in water (A) and acetonitrile (B), which was deaerated by sonication before use. Linear gradient elution was performed for 20 min from 38 to 50% B in 3 min, from 50 to 52% B in 7 min, and from 85 to 90% B in 10 min. A re-equilibration period of 12 min was used between individual runs. Chromatography was performed at 25°C with a flow rate of 0.2 ml · min
Ϫ1
. Chromatographic peaks were identified and purity was estimated with an HP1100 Series Photodiode Array Detector.
Preparation of Standards An original standard solution was prepared by dissolving GL, GA and GAMG (1.07-3.96 mg) in methanol (2 ml), and was diluted to make methanolic standard solutions (0.095-247 mg · ml
). Calibration curves were generated using ten different concentrations of standard solutions from least-squares regression of peak area in triplicate assays.
Preparation of a Rat Fecal Suspension Fresh feces (1.0 g) obtained from male Wistar rats (200 g) were homogenized in 0.1 M potassium phosphate buffer (25 ml, pH 7.4) by bubbling with CO 2 gas to eliminate air, and the sediments were removed by filtration through gauze.
10) The filtrate was used as a fecal suspension in this experiment.
Incubation of Shakuyaku-kanzo-to with Rat Fecal Suspension A decoction of Shakuyaku-kanzo-to (0.25 ml) was incubated with a fecal suspension (1 ml) at 37°C under anaerobic conditions. After 2 h, 0.85% phosphoric acid in methanol (1.25 ml) was added. The mixture was then centrifuged and the supernatant was passed through a Minisart-RC 15 filter and subjected to HPLC as the incubation mixture.
Interference Trial and Peak Purity Variant decoction (blank decoction), in which peony root was excluded, was also prepared as described above. The purity of the peaks was checked by diode-array detection. The UV spectra of peaks at five different points (upslope, top and downslope) were compared with those of authentic specimens.
Recovery Standard solution was prepared by diluting GL (84.0 mM), GA (79.8 mM) and GAMG (28.2 mM) with a mixture (diluent) of water, 0.1 M phosphate buffer (pH 7.4) and methanol with 0.85% phosphoric acid (1 : 4 : 5) to 2-, 4-, 8-and 16-fold dilution. The test solutions were prepared by addition of incubation mixture or diluent (0.5 ml) to standard solution (0.5 ml). All test solutions were filtered through a Minisart-RC 15 filter and subjected to HPLC. The recoveries were determined from the slope ratios of regression equations with/without the incubation mixture.
RESULTS AND DISCUSSION
Use of a semi-micro column with a narrow internal diameter has several advantages, the most important being increased detectability and lower solvent consumption. When a sample is injected onto a 2.0 mm i.d. column, the peak is 5.29-fold higher than when the same amount of sample is injected onto a 4.6 mm i.d. column. This greatly facilitated detection of trace components. In addition, minimizing the quantity of solvent used for analysis is desirable from the viewpoint of reducing environmental pollution.
Adequate separation of GL, GAMG and GA was achieved as shown in Fig. 1 . The retention times (and capacity factors, kЈ) were 7.90 (GL, kЈϭ4.91), 13.46 (GAMG, kЈϭ9.06) and 19.18 min (GA, kЈϭ13.33). The relative standard deviations (RSD, nϭ10) of retention time were 0.14, 0.12 and 0.04%. These peaks were identified by comparison with authentic specimens on inspection of retention times and UV spectra, and the purity was checked by three-dimensional chromatography. Linearity of these compounds was evaluated over the range of 1.75 to 301 mM for GL, 0.207 to 207 mM for GAMG and 0.204 to 130 mM for GA. The regression equations were yϭ9.99xϪ13.51 for GL, yϭ9.41xϪ0.44 for GAMG and yϭ 10.5xϩ0.96 for GA with a correlation coefficient of 1.0000, where y is the peak-area and x is the concentration ( mM) of marker components. The detection limits (signal-to-noise ratioϭ3) of GL, GAMG and GA were 0.85, 0.3 and 0.1 pmol per injection (5 ml), respectively. The marker substances were clearly separated without any pre-purification and determined within 20 min without any pre-cleaning of the column. Distinct elution profiles of marker substances were obtained without any interference from the decoction, prepared by excluding licorice root from Shakuyaku-kanzo-to. A peak at 4.82 min (kЈϭ2.60) was attributed to liquiritigenin, the aglycone of liquiritin, in licorice root.
The within-day and between-day precision of the method for detection of each marker substance was evaluated by using decoction and incubation mixture of Shakuyakukanzo-to and standard mixture of the marker substances. The within-day precision was examined with ten replicate assays per day and the between-day precision by assays on five different days. As shown in Table 1 , the within-day and between-day RSDs were within 0.12 to 0.64% and 0.05 to 2.13%, respectively. The marker substances were stable in both standard mixture and incubation mixture for over 6 days at 4°C by the between-day assay. Recovery was investigated using incubation mixture of Shakuyaku-kanzo-to spiked with a standard solution of the marker substances. The slopes of regression equations of standards and the recoveries by this method are shown in Table 2 . The recoveries of marker substances were 97.8% for GL and GAMG and 96.5% for GA.
Kampo medicine was originally used in the form of decoc- tions prepared by boiling crude drugs according to formulas in classic texts. Licorice root is a crude drug contained in more than 70% of Kampo medicines certified by the Japanese Ministry of Health and Welfare.
3) The major ingredient GL is also used in the treatment of various diseases. We applied the present procedure to determine GL in Shakuyakukanzo-to decoction. The concentration of GL was 50.1Ϯ0.71 mg per gram of licorice root, in good agreement with the value obtained by another HPLC method.
11) Kampo medicines are orally administered so that glycosides present are usually absorbed after being hydrolyzed to the corresponding aglycone by intestinal bacteria. In fact, GL administered orally may be absorbed in the form of GA and shows various pharmacological effects as a natural prodrug.
12) Administration of Shakuyaku-kanzo-to to women one week before menses is believed to be effective for menstrual pain, because GL will be successfully metabolized within this time frame. 13) In a preliminary experiment on the metabolism of glycosides, liquiritin, liquiritin apioside and paeoniflorin in Shakuyaku-kanzo-to were shown to be almost completely hydrolyzed in rat fecal suspension under anaerobic conditions for 4, 8 and 12 h, respectively (unpublished data). The metabolism of GL was, however, so slowly that approximately 40% of GL remained in the incubation mixture for 24 h. This may be explained by the differences in activities of bacterial enzymes against glucosides and glucuronides. Therefore, a method for the determination of GL, GA and GAMG is necessary to investigate the bioavailability of GL, which is clinically important for understanding the efficacy and safety of Kampo medicines and herbal medicines containing licorice root. Although there have been many reports dealing with HPLC determination of GL or GA independently, none of these methods were sufficiently sensitive for the simultaneous determination of GL, GA and GAMG. Using the present HPLC method, however, we were able to determine small amounts of GL and its metabolites simultaneously.
Shakuyaku-kanzo-to was anaerobically incubated with fecal suspensions obtained from fresh rat feces. HPLC analysis of incubation mixtures showed a small peak due to GA, which was not detected in the decoction of Shakuyakukanzo-to ( Fig. 2A-1) . No significant endogenous peaks coeluted with the marker substances were observed in the corresponding chromatogram of Shakuyaku-kanzo-to-free incubation mixture ( Fig. 2A-2) . A typical chromatogram obtained from the consumption of Shakuyaku-kanzo-to (ca. 40 mg GL per day) as drinking fluid ad libitum for five days is shown in Fig. 2B-1 . Substantial amount of GA was found in the incubation mixture in which 2 or 3 of 5 fecal suspensions showed a marked effect for metabolism of GL, while the others were similar to the chromatographic profile of untreated controls. This may reflect individual variation in conversion ratio from GL to GA by intestinal bacteria. In a fecal suspension when Shakuyaku-kanzo-to was orally consumed, only traces of the metabolite GA and no GL were detected (blank, Fig. 2B-2) . Table 3 shows the concentrations of GL and its metabolites in the two groups. The values of GL and GA in the consumption group were significantly different from those in the untreated controls. In addition, although large individual differences were observed, a small or large quantity of GAMG was frequently found in the consumption group, while GAMG was not detected in the control group. These results were confirmed by examination of the incubation mixture after oral consumption of GL instead of Shakuyaku-kanzo-to. After oral administration to humans and rats, GL absorbed in intact form from the gastrointestinal tract is metabolized to GAMG in the epithelial cells of the gastrointestinal tract. 14) In fact, GAMG is believed to be an intermediate in the hydrolysis of GL to GA, but GAMG metabolized from GL by intestinal bacteria has not been reported previously. Our findings suggested that GL is converted to GAMG in fecal suspension, although it is not clear whether GAMG is a metabolic intermediate.
The method described in this report is sufficiently sensitive and reliable to be used for the simultaneous determination of GL and its metabolites. In addition, we demonstrated GL-hydrolysis using rat feces under anaerobic conditions and found that significantly high levels of GA were achieved by continuous oral consumption of Shakuyaku-kanzo-to or GL for five days. This suggested that premedication with Shakuyakukanzo-to or GL accelerates the conversion of GL to GA, which may be useful when a stronger efficacy of GL metabolites is expected. 
